Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. SenesTech, Inc.
  6. Summary
    SNES   US81720R2085

SENESTECH, INC.

(SNES)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2021 10/21/2021 10/22/2021 10/25/2021 10/26/2021 Date
1.52(c) 1.51(c) 1.4812(c) 1.46(c) 1.48 Last
20 990 38 410 31 848 103 228 4 845 730 Volume
-1.94% -0.66% -1.91% -1.43% +1.37% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 0,75 M - -
Net income 2021 -9,10 M - -
Net Debt 2021 - - -
P/E ratio 2021 -2,00x
Yield 2021 -
Sales 2022 1,93 M - -
Net income 2022 -10,1 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,95x
Yield 2022 -
Capitalization 18,0 M 18,0 M -
Capi. / Sales 2021 24,0x
Capi. / Sales 2022 9,33x
Nbr of Employees 29
Free-Float 89,5%
More Financials
Company
SenesTech, Inc. is developing and commercializing a globaltechnology for managing animal pest populations, initially rat populations, through fertility control. The CompanyÔÇÖs product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest is a liquid bait containing the active ingredients four vinylcyclohexene diepoxide (VCD) and triptolide.... 
More about the company
Ratings of SenesTech, Inc.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SENESTECH, INC.
04:16pNewton, Massachusetts Joins Cities Across the U.S. Using ContraPest« to Control Soaring..
PR
10/07SENESTECH : Investor Presentation - October 2021
PU
09/30SENESTECH : to Present at the Lytham Partners Fall 2021 Investor Conference
PR
08/18INSIDER TRENDS : Insider Purchase Eases Back 90-Day Trend of Sales at SenesTech
MT
08/13SENESTECH : Management's Discussion and Analysis of Financial Condition and Results of Ope..
AQ
08/12SENESTECH : Announces 2021 Second Quarter Financial and Operational Results (Form 8-K)
PU
08/12SENESTECH : Earnings Flash (SNES) SENESTECH Reports Q2 Revenue $160,000, vs. Street Est of..
MT
08/12SENESTECH, INC. : Results of Operations and Financial Condition, Financial Statements and ..
AQ
08/12Senestech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/12SENESTECH : Announces 2021 Second Quarter Financial and Operational Results
PR
08/03SENESTECH : to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021
PR
07/08SENESTECH : Investor Presentation - July 2021
PU
06/25SENESTECH, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vo..
AQ
06/17SENESTECH : AMENDMENT NO. 1 TO THE AMENDED AND RESTATED BYLAWS OF SENESTECH, INC (Form 8-K..
PU
06/17SENESTECH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financi..
AQ
More news
News in other languages on SENESTECH, INC.

- No features available -

More news
Analyst Recommendations on SENESTECH, INC.
More recommendations
Chart SENESTECH, INC.
Duration : Period :
SenesTech, Inc. Technical Analysis Chart | SNES | US81720R2085 | MarketScreener
Technical analysis trends SENESTECH, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,48 $
Average target price 4,00 $
Spread / Average Target 170%
EPS Revisions
Managers and Directors
Kenneth S. Siegel Chief Executive Officer & Director
Thomas C. Chesterman Chief Financial Officer & Treasurer
Jamie Bechtel Morrison Chairman
Brandy Pyzyna Vice President-Research & Regulatory Affairs
Kim Wolin Secretary & Executive Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
SENESTECH, INC.-14.20%18
MODERNA, INC.230.95%141 099
LONZA GROUP AG31.93%60 646
IQVIA HOLDINGS INC.42.93%49 145
SEAGEN INC.1.46%31 933
CELLTRION, INC.-38.02%25 328